Type 2 Diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants must be adults diagnosed with Type 2 diabetes currently hospitalized Aged 18 years or older Alert, and capable of providing informed consent Participants should demonstrate the ability to comprehend and adhere to verbal instructions Be undergoing regular subcutaneous insulin injections Not have administered any analgesic medications for a minimum duration of 8 hours prior to the injection.
Exclusion criteria
Exclusion criteria: Patients diagnosed with Type 2 diabetes for a duration of 10 years or more Suffered trauma near the injection site Patients exhibiting cognitive impairments or mental health disorders that hinder their capacity to understand or provide consent Patients presenting with active infections or complications at the injection site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable is the level of pain that can be changed. based on Vibration or coughing technique or ShotBlocke. Timepoint: for 2-3 seconds before needle insertion. immediately after subcutaneous insulin injection when using the ShotBlocker, vibration device, and coughing technique. The level of pain will be measured. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome variable is the level of patient satisfaction that can be changed based on vibration device or coughing techniqe or shotblocker. Timepoint: for 2-3 seconds before needle insertion. immediately after subcutaneous insulin injection when using the ShotBlocker, vibration device, and coughing technique.the level of satisfaction will be measured. Method of measurement: Visual Individual Satisfaction Scale (VISS). | — |
Countries
Iraq
Contacts
College of nursing,University of Baghdad